Skip to main content
. 2021 Feb 7;13(4):669. doi: 10.3390/cancers13040669

Figure 7.

Figure 7

Two approaches towards discovering drug vulnerabilities using CRISPR-Cas9 genome-wide screens: vulnerabilities that are derived from a specific genetic contexts (a) and drug-related vulnerabilities (b).